Cancer treatments are typically expensive due to several factors. Firstly, the cost of advanced diagnostic tools, such as MRI and PET scans, is substantial. Secondly, the treatments themselves, including chemotherapy, radiation therapy, and surgery, involve sophisticated technology and specialized expertise. Additionally, new and innovative treatments, such as immunotherapy and targeted therapy, often come with high price tags due to research and development costs. Moreover, the complexity of managing cancer requires a multidisciplinary team, including oncologists, radiologists, pathologists, and surgeons, each contributing to the overall cost.
